Could poop pills heal gut damage in rare immune disease?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Aged \>=10 to \<=60 years. 2. Able to provide informed consent (for ages \>=18 years) or has a parent or guardian who can provide informed consent on their behalf (for ages \<18 years). 3. Have confirmed prior diagnoses of CGD and CGD-AC (or CGD-IBD with evidence of colitis on colonoscopy). 4. Fecal calprotectin level \>=200 microgram/g. 5. HBI score \>=5 (to be evaluated on Day 1). 6. No planned change in systemic antibiotic regimen for CGD for 1 month preceding FMT. 7. No planned escalation in CGD-IBD treatment for 1 month preceding FMT. 8. If taking monoclonal antibodies for CGD-IBD, the dose must be stable for 12 weeks with no planned escalation. 9. Participants who can become pregnant must agree to use at least one highly effective method of contraception when engaging in sexual activities that can result in pregnancy, starting at screening until the end of study participation. Highly effective methods include a barrier (eg, condom, diaphragm, cervical cap), intrauterine device, or hormonal contraception. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: 1. Evidence of acute GI infection, including active GI abscesses. 2. Presence of C difficile toxin gene in stool, as identified by PCR, in screening period. 3. History of intestinal obstruction definitively related to CGD-IBD. 4. History of fistulizing CGD-IBD or CGD-IBD intra-abdominal abscesses. 5. History of CGD-IBD related non-transversable intestinal strictures. 6. History of AEs attributable to previous FMT. 7. History of significant liver disease (eg, biopsy-proven nodular regenerative hyperplasia), including portal hypertension or cirrhosis. 8. Pregnant or breastfeeding. 9. History of severe food allergy. 10. Any contraindication to having colonoscopy under anesthesia. 11. Any condition that, in the opinion of the investigator, contraindicates participation in this study.